Patents by Inventor Sung-Hak Choi
Sung-Hak Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240098001Abstract: The present disclosure relates to a data management system and method and, more particularly, to a data management system and method using a docker system in an edge computing environment, the system and method collecting and managing data for each of control operation targets and each of characteristic of the control operation targets using a docker system in an edge computing-cloud computing linkage environment, and enabling an edge server to stably operate in accordance with the characteristics of the control operation targets even though communication between the edge server of an edge computing environment and a cloud server is impossible.Type: ApplicationFiled: September 12, 2023Publication date: March 21, 2024Applicant: Kevinlab Co.Inventors: Kyung Hak KIM, Sung Hwan CHOI
-
Patent number: 11923562Abstract: A battery module includes: a battery cell assembly having a plurality of battery cells; a top plate configured to cover an upper side of the battery cell assembly; a bottom plate configured to cover a lower side of the battery cell assembly; a sensing assembly disposed to cover a front side and a rear side of the battery cell assembly; a pair of side plates disposed at side surfaces, respectively, of the battery cell assembly; and a pair of compression pads disposed between the pair of side plates and the battery cell assembly, respectively.Type: GrantFiled: November 1, 2022Date of Patent: March 5, 2024Assignee: LG Energy Solution, Ltd.Inventors: Sung-Won Seo, Dong Yeon Kim, Ho-June Chi, Dal-Mo Kang, Jin-Hak Kong, Jeong-O Mun, Yoon-Koo Lee, Yong-Seok Choi, Alexander Eichhorn, Andreas Track
-
Publication number: 20230348725Abstract: Provided are an optical member and an optical display device including same, the optical member comprising: a base film; and a light transmission control layer stacked on the lower surface of the base film, wherein the light transmission control layer comprises: a dye or dye mixture including at least one of a first dye having a maximum absorption wavelength of about 540 nm to about 630 nm, a second dye having a maximum absorption wavelength of about 390 nm to about 470 nm, a third dye having a maximum absorption wavelength of about 480 nm to about 530 nm, and a fourth dye having a maximum absorption wavelength of about 640 nm to about 760 nm; and a resin having a hydroxyl value of 5 mgKOH/g or less.Type: ApplicationFiled: March 26, 2021Publication date: November 2, 2023Inventors: Sung Hak CHOI, Jae Sun HAN
-
Patent number: 10160724Abstract: The present disclosure relates to a novel tetrahydropyridine derivative compound, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, methods for preparing the compounds, methods for inhibiting UDP-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC), methods for treating Gram-negative bacterial infections, the use of the compounds for the preparation of therapeutic medicaments for treating Gram-negative bacterial infections, and pharmaceutical compositions for prevention or treatment of Gram-negative bacterial infections, which contain the compounds. The compounds represented by formula I, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present disclosure can exhibit excellent effects on the treatment bacterial infections.Type: GrantFiled: September 28, 2017Date of Patent: December 25, 2018Assignee: Dong-A St Co., Ltd.Inventors: Sun-Ho Choi, Weon-Bin Im, Sung-Hak Choi, Chong-Hwan Cho, Ho-Sang Moon, Jung-Sang Park, Min-Jung Lee, Hyun-Jung Sung, Jun-Hwan Moon, Seung-Hyun Song, Hyung-Keun Lee, Ji-Hoon Choi, Cheon-Hyoung Park, Yoon-Jung Kim, Jin-Hyuk Kim
-
Publication number: 20180086709Abstract: The present disclosure relates to a novel tetrahydropyridine derivative compound, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, methods for preparing the compounds, methods for inhibiting UDP-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC), methods for treating Gram-negative bacterial infections, the use of the compounds for the preparation of therapeutic medicaments for treating Gram-negative bacterial infections, and pharmaceutical compositions for prevention or treatment of Gram-negative bacterial infections, which contain the compounds. The compounds represented by formula I, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present disclosure can exhibit excellent effects on the treatment bacterial infections.Type: ApplicationFiled: September 28, 2017Publication date: March 29, 2018Inventors: Sun-Ho Choi, Weon-Bin Im, Sung-Hak Choi, Chong-Hwan Cho, Ho-Sang Moon, Jung-Sang Park, Min-Jung Lee, Hyun-Jung Sung, Jun-Hwan Moon, Seung-Hyun Song, Hyung-Keun Lee, Ji-Hoon Choi, Cheon-Hyoung Park, Yoon-Jung Kim, Jin-Hyuk Kim
-
Patent number: 9828339Abstract: Provided are biphenyl derivatives having the structure of Formula 1: stereoisomers thereof, and pharmaceutically acceptable salts thereof, wherein R1 is hydrogen, halogen, hydroxy, substituted or unsubstituted C1-C6 alkyl, or C1-C6 alkoxy; R2, R3 and R4 are each independently hydrogen, halogen, substituted or unsubstituted amino, nitro, cyano, hydroxy, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C1-C6 alkoxy, or —C(O)R6; R5 is hydrogen or C1-C6 alkyl; n is 0 or 1; and R6 is hydrogen or amino, methods for preparing the same, and a pharmaceutical composition containing the same.Type: GrantFiled: July 17, 2014Date of Patent: November 28, 2017Assignee: DONG-A ST CO., LTDInventors: Soon-Hoe Kim, Weon-Bin Im, Chong-Hwan Cho, Sun-Ho Choi, Jung-Sang Park, Mi-Yeon Kim, Sung-Hak Choi, Min-Jung Lee, Kang-Hun Cho
-
Publication number: 20170333414Abstract: The present invention relates to novel derivatives of oxazolidinone, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone derivatives of the present invention show inhibitory activity against a broad spectrum of bacteria and lower toxicity. The prodrugs, prepared by reacting the compound having hydroxyl group with amino acid or phosphate, have an excellent efficiency on solubility thereof against water. Further, the derivatives of the present invention may exert potent antibacterial activity versus various human and animal pathogens, including Gram-positive bacteria such as Staphylococi, Enterococci and Streptococi, anaerobic microorganisms such as Bacteroides and Clostridia, and acid-resistant microorganisms such as Mycobacterium tuberculosis and Mycobacterium avium. Accordingly, the compositions comprising the oxazolidinone are used in an antibiotic.Type: ApplicationFiled: June 7, 2017Publication date: November 23, 2017Inventors: Jae Keol Rhee, Weon Bin Im, Chong Hwan Cho, Sung Hak Choi, Tae Ho Lee
-
Patent number: 9676796Abstract: The present invention relates to a novel tricyclic benzoxaborole derivative, a preparation method thereof, and use of antibiotics pharmaceutical composition including the same as an active ingredient.Type: GrantFiled: July 28, 2014Date of Patent: June 13, 2017Assignee: DONG-A ST CO., LTD.Inventors: Soon-Hoe Kim, Weon-Bin Im, Seung-Bum Ha, Jung-Sang Park, Mi-Yeon Kim, Sung-Hak Choi, Hyun-Jung Sung
-
Publication number: 20170049763Abstract: The present invention relates to novel derivatives of oxazolidinone, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone derivatives of the present invention show inhibitory activity against a broad spectrum of bacteria and lower toxicity. The prodrugs, prepared by reacting the compound having hydroxyl group with amino acid or phosphate, have an excellent efficiency on solubility thereof against water. Further, the derivatives of the present invention may exert potent antibacterial activity versus various human and animal pathogens, including Gram-positive bacteria such as Staphylococi, Enterococci and Streptococi, anaerobic microorganisms such as Bacteroides and Clostridia, and acid-resistant microorganisms such as Mycobacterium tuberculosis and Mycobacterium avium. Accordingly, the compositions comprising the oxazolidinone are used in an antibiotic.Type: ApplicationFiled: August 30, 2016Publication date: February 23, 2017Inventors: JAE KEOL RHEE, WEON BIN IM, CHONG HWAN CHO, SUNG HAK CHOI, TAE HO LEE
-
Patent number: 9409130Abstract: A submerged-type hollow fiber membrane module and a method for manufacturing the same are disclosed, which is capable of realizing a great sealing strength between a module case and a bundle of hollow fiber membranes without an additional centrifugal molding apparatus. The method includes forming a bundle of hollow fiber membranes held together and fixed by a first potting material, wherein one end of each of the hollow fiber membranes is open; putting the bundle of hollow fiber membranes in a module case and fixing the bundle of hollow fiber membranes in the module case by forming a second potting material on the first potting material.Type: GrantFiled: October 19, 2009Date of Patent: August 9, 2016Assignee: KOLON INDUSTRIES, INC.Inventors: Moo-Seok Lee, Sung-Hak Choi
-
Publication number: 20160176816Abstract: The present invention provides novel biphenyl derivatives, isomers thereof, or pharmaceutically acceptable salts thereof, methods for preparing the same, and a pharmaceutical composition containing the same. The novel biphenyl derivatives, isomers thereof, or pharmaceutically acceptable salts thereof, as disclosed in the present invention, act as muscarinic M3 receptor antagonists, and thus are useful for the prevention or treatment of a disease selected from the group consisting of chronic obstructive pulmonary disease, asthma, irritable bowel syndrome, urinary incontinence, rhinitis, spasmodic colitis, chronic cystitis, Alzheimer's disease, senile dementia, glaucoma, schizophrenia, gastroesophageal reflux disease, cardiac arrhythmia, and hyper-salivation syndromes.Type: ApplicationFiled: July 17, 2014Publication date: June 23, 2016Inventors: Soon-Hoe KIM, Weon-Bin IM, Chong-Hwan CHO, Sun-Ho CHOI, Jung-Sang PARK, Mi-Yeon KIM, Sung-Hak CHOI, Min-Jung LEE, Kang-Hun CHO
-
Publication number: 20160168167Abstract: The present invention relates to a novel tricyclic benzoxaborole derivative, a preparation method thereof, and use of antibiotics pharmaceutical composition including the same as an active ingredient.Type: ApplicationFiled: July 28, 2014Publication date: June 16, 2016Applicant: DONG-A ST CO., LTD.Inventors: Soon-Hoe Kim, Weon-Bin Im, Seung-Bum Ha, Jung-Sang Park, Mi-Yeon Kim, Sung-Hak Choi, Hyun-Jung Sung
-
Patent number: 9221790Abstract: The present invention provides a novel benzamide derivative or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a 5-HT4 receptor agonist containing the same as an active ingredient. Benzamide derivatives of the present invention have a superior affinity for 5-HT4 receptors, a capability to reduce a gastric emptying time and a low toxicity, and consequently are therapeutically effective for the treatment of a variety of diseases associated with 5-HT4 receptors.Type: GrantFiled: April 18, 2011Date of Patent: December 29, 2015Assignee: Dong-A Pharm. Co., Ltd.Inventors: Soon-Hoe Kim, Weon-Bin Im, Sung-Hak Choi, Sun-Ho Choi, Ju-Hee Sohn, Hyun-Jung Sung, Mi-Yeon Kim, Kang-Hun Cho, Tae-Kyoung Sohn
-
Patent number: 9163043Abstract: The present invention relates to novel derivatives of oxazolidinone, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone derivatives of the present invention show inhibitory activity against a broad spectrum of bacteria and lower toxicity. The prodrugs, prepared by reacting the compound having hydroxyl group with amino acid or phosphate, have an excellent efficiency on solubility thereof against water. Further, the derivatives of the present invention may exert potent antibacterial activity versus various human and animal pathogens, including Gram-positive bacteria such as Staphylococi, Enterococci and Streptococi, anaerobic microorganisms such as Bacteroides and Clostridia, and acid-resistant microorganisms such as Mycobacterium tuberculosis and Mycobacterium avium. Accordingly, the compositions comprising the oxazolidinone are used in an antibiotic.Type: GrantFiled: April 15, 2013Date of Patent: October 20, 2015Assignee: DONG-A ST CO., LTD.Inventors: Jae Keol Rhee, Weon Bin Im, Chong Hwan Cho, Sung Hak Choi, Tae Ho Lee
-
Publication number: 20140350059Abstract: The present invention relates to novel derivatives of oxazolidinone, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone derivatives of the present invention show inhibitory activity against a broad spectrum of bacteria and lower toxicity. The prodrugs, prepared by reacting the compound having hydroxyl group with amino acid or phosphate, have an excellent efficiency on solubility thereof against water. Further, the derivatives of the present invention may exert potent antibacterial activity versus various human and animal pathogens, including Gram-positive bacteria such as Staphylococi, Enterococci and Streptococi, anaerobic microorganisms such as Bacteroides and Clostridia, and acid-resistant microorganisms such as Mycobacterium tuberculosis and Mycobacterium avium. Accordingly, the compositions comprising the oxazolidinone are used in an antibiotic.Type: ApplicationFiled: August 13, 2014Publication date: November 27, 2014Inventors: Jae Keol RHEE, Weon Bin IM, Chong Hwan CHO, Sung Hak CHOI, Tae Ho LEE
-
Publication number: 20130281492Abstract: The present invention relates to novel derivatives of oxazolidinone, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone derivatives of the present invention show inhibitory activity against a broad spectrum of bacteria and lower toxicity. The prodrugs, prepared by reacting the compound having hydroxyl group with amino acid or phosphate, have an excellent efficiency on solubility thereof against water. Further, the derivatives of the present invention may exert potent antibacterial activity versus various human and animal pathogens, including Gram-positive bacteria such as Staphylococi, Enterococci and Streptococi, anaerobic microorganisms such as Bacteroides and Clostridia, and acid-resistant microorganisms such as Mycobacterium tuberculosis and Mycobacterium avium. Accordingly, the compositions comprising the oxazolidinone are used in an antibiotic.Type: ApplicationFiled: April 15, 2013Publication date: October 24, 2013Inventors: Jae Keol Rhee, Weon Bin Im, Chong Hwan Cho, Sung Hak Choi, Tae Ho Lee
-
Patent number: 8420676Abstract: The present invention relates to novel derivatives of oxazolidinone, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone derivatives of the present invention show inhibitory activity against a broad spectrum of bacteria and lower toxicity. The prodrugs, prepared by reacting the compound having hydroxyl group with amino acid or phosphate, have an excellent efficiency on solubility thereof against water. Further, the derivatives of the present invention may exert potent antibacterial activity versus various human and animal pathogens, including Gram-positive bacteria such as, Staphylococci, Enterococci and Streptococci anaerobic microorganisms such as Bacteroides and Clostridia, and acid-resistant microorganisms such as Mycobacterium tuberculosis and Mycobacterium avium. Accordingly, the compositions comprising the oxazolidinone are used in an antibiotic.Type: GrantFiled: September 16, 2008Date of Patent: April 16, 2013Assignee: Dong-A Pharmaceuticals Co. Ltd.Inventors: Jae Keol Rhee, Weon Bin Im, Chong Hwan Cho, Sung Hak Choi, Tae Ho Lee
-
Publication number: 20130085160Abstract: The present invention provides a novel benzamide derivative or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a 5-HT4 receptor agonist containing the same as an active ingredient. Benzamide derivatives of the present invention have a superior affinity for 5-HT4 receptors, a capability to reduce a gastric emptying time and a low toxicity, and consequently are therapeutically effective for the treatment of a variety of diseases associated with 5-HT4 receptors.Type: ApplicationFiled: April 18, 2011Publication date: April 4, 2013Inventors: Soon-Hoe Kim, Weon-Bin Im, Sung-Hak Choi, Sun-Ho Choi, Ju-Hee Sohn, Hyun-Jung Sung, Mi-Yeon Kim, Kang-Hun Cho, Tae-Kyoung Sohn
-
Patent number: 8201485Abstract: A tubular braid and a composite hollow fiber membrane using the same are disclosed. The tubular braid is made by braiding yarns, the yarn made by combining thin filament and thick filament, wherein the thin filament is comprised of a plurality of monofilament having a fineness of 0.01 to 0.4 denier, and the thick filament is comprised of at least one monofilament having a fineness of 3 to 50 denier. Also, the composite hollow fiber membrane using the tubular braid of the present invention can realize excellent water permeability, high mechanical strength, good filtration reliability, great peeling strength, low dope permeation, and high stiffness.Type: GrantFiled: February 5, 2008Date of Patent: June 19, 2012Assignee: KOLON Industries, Inc.Inventors: Moo-Seok Lee, Joon-Khee Yoon, Sung-Hak Choi, Yong-Cheol Shin
-
Patent number: 7816379Abstract: The present invention relates to novel derivatives of oxazolidinone, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone derivatives of the present invention show inhibitory activity against a broad spectrum of bacteria and lower toxicity. The prodrugs, prepared by reacting the compound having hydroxyl group with amino acid or phosphate, have an excellent efficiency on solubility thereof against water. Further, the derivatives of the present invention may exert potent antibacterial activity versus various human and animal pathogens, including Gram-positive bacteria such as Staphylococi, Enterococci and Streptococi, anaerobic microorganisms such as Bacteroides and Clostridia, and acid-resistant microorganisms such as Mycobacterium tuberculosis and Mycobacterium avium. Accordingly, the compositions comprising the oxazolidinone are used in an antibiotic.Type: GrantFiled: December 17, 2004Date of Patent: October 19, 2010Assignee: Dong-A Pharm. Co., Ltd.Inventors: Jae Keol Rhee, Weon Bin Im, Chong Hwan Cho, Sung Hak Choi, Tae Ho Lee